Prostate-Specific Antigen (PSA) Diagnostic, Serum
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Evaluating patients with documented prostate problems in whom multiple prostate-specific antigen tests may be necessary per year
Monitoring patients with a history of prostate cancer as an early indicator of recurrence and response to treatment
Electrochemiluminescent Immunoassay (ECLIA)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
PSA, S MMLNE only